Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | JAM3 |
| Upstream (Parents) |
|---|
| (<<) GLT8D2 → JAM3 |
| (<<) OLFML1 → JAM3 |
| Downstream (Children) |
|---|
| JAM3 → DCHS1 (>>) |
| JAM3 → PCDHB16 (>>) |
| JAM3 → CNTN1 (>>) |
| JAM3 → NAP1L3 (>>) |
| JAM3 → SMOC2 (>>) |
| JAM3 → MMP16 (>>) |
| JAM3 → CPE (>>) |
| JAM3 → PROS1 (>>) |
| JAM3 → AKAP12 (>>) |
| JAM3 → PRRG4 (>>) |
| JAM3 → IGDCC4 (>>) |
| JAM3 → FEZ1 (>>) |
| JAM3 → FRY (>>) |
| JAM3 → FMOD (>>) |
| JAM3 → IRS1 (>>) |
| JAM3 → CAV1 (>>) |
| JAM3 → ITGB5 (>>) |
| JAM3 → FKBP1B (>>) |
| JAM3 → PCDH18 (>>) |
| JAM3 → DLL1 (>>) |
| JAM3 → GAS6 (>>) |
| JAM3 → PRICKLE2 (>>) |
| JAM3 → SEMA5A (>>) |
| JAM3 → NAV3 (>>) |
| JAM3 → ZCCHC24 (>>) |
| JAM3 → RECK (>>) |
| JAM3 → PDE5A (>>) |
| JAM3 → PDGFA (>>) |
| JAM3 → CRISPLD2 (>>) |
| JAM3 → OLFML1 (>>) |
| JAM3 → PELI2 (>>) |
| JAM3 → C11orf63 (>>) |
| JAM3 → C5orf53 (>>) |
| JAM3 → LOC100130360 (>>) |
| JAM3 → FLJ10357 (>>) |
| JAM3 → ARHGAP28 (>>) |
| JAM3 → CYP2U1 (>>) |
| JAM3 → PLA2R1 (>>) |
| JAM3 → C10orf72 (>>) |
| JAM3 → SH3D19 (>>) |
| JAM3 → LAYN (>>) |
| JAM3 → FBXL7 (>>) |
| JAM3 → LOC400043 (>>) |
| JAM3 → CACNA2D3 (>>) |
| JAM3 → ARID5B (>>) |
| JAM3 → KANK2 (>>) |
| JAM3 → RCAN2 (>>) |
